These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20148565)

  • 1. Antitumor agents. 272. Structure-activity relationships and in vivo selective anti-breast cancer activity of novel neo-tanshinlactone analogues.
    Dong Y; Shi Q; Pai HC; Peng CY; Pan SL; Teng CM; Nakagawa-Goto K; Yu D; Liu YN; Wu PC; Bastow KF; Morris-Natschke SL; Brossi A; Lang JY; Hsu JL; Hung MC; Lee EY; Lee KH
    J Med Chem; 2010 Mar; 53(5):2299-308. PubMed ID: 20148565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor agents. 254. Synthesis and biological evaluation of novel neo-tanshinlactone analogues as potent anti-breast cancer agents.
    Wang X; Nakagawa-Goto K; Bastow KF; Don MJ; Lin YL; Wu TS; Lee KH
    J Med Chem; 2006 Sep; 49(18):5631-4. PubMed ID: 16942038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor agents. 266. Design, synthesis, and biological evaluation of novel 2-(furan-2-yl)naphthalen-1-ol derivatives as potent and selective antibreast cancer agents.
    Dong Y; Shi Q; Liu YN; Wang X; Bastow KF; Lee KH
    J Med Chem; 2009 Jun; 52(11):3586-90. PubMed ID: 19425534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor agents 270. Novel substituted 6-phenyl-4H-furo[3,2-c]pyran-4-one derivatives as potent and highly selective anti-breast cancer agents.
    Dong Y; Shi Q; Nakagawa-Goto K; Wu PC; Morris-Natschke SL; Brossi A; Bastow KF; Lang JY; Hung MC; Lee KH
    Bioorg Med Chem; 2010 Jan; 18(2):803-8. PubMed ID: 20034799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neo-tanshinlactone inspired synthesis, in vitro evaluation of novel substituted benzocoumarin derivatives as potent anti-breast cancer agents.
    Sashidhara KV; Rosaiah JN; Kumar M; Gara RK; Nayak LV; Srivastava K; Bid HK; Konwar R
    Bioorg Med Chem Lett; 2010 Dec; 20(23):7127-31. PubMed ID: 20951035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular hybridization used to design and synthesize neo-tanshinlactone derivatives as PD-1/PD-L1 inhibitors.
    Zhang M; Liu J; Wang Y; Wang P; Morris-Natschke S; Lee KH
    Bioorg Med Chem; 2022 Jan; 54():116579. PubMed ID: 34954618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor Agents. 239. Isolation, structure elucidation, total synthesis, and anti-breast cancer activity of neo-tanshinlactone from Salvia miltiorrhiza.
    Wang X; Bastow KF; Sun CM; Lin YL; Yu HJ; Don MJ; Wu TS; Nakamura S; Lee KH
    J Med Chem; 2004 Nov; 47(23):5816-9. PubMed ID: 15509181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor agents 269. Non-aromatic ring-A neotanshinlactone analog, TNO, as a new class of potent antitumor agents.
    Dong Y; Shi Q; Nakagawa-Goto K; Wu PC; Bastow KF; Morris-Natschke SL; Lee KH
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6289-92. PubMed ID: 19819136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neo-tanshinlactone D-ring modified novel analogues induce apoptosis in human breast cancer cell via DNA damage.
    Banerji B; Killi SK; Katarkar A; Chatterjee S; Tangella Y; Prodhan C; Chaudhuri K
    Bioorg Med Chem; 2017 Jan; 25(1):202-212. PubMed ID: 27814949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor agents 279. Structure-activity relationship and in vivo studies of novel 2-(furan-2-yl)naphthalen-1-ol (FNO) analogs as potent and selective anti-breast cancer agents.
    Dong Y; Nakagawa-Goto K; Lai CY; Kim Y; Morris-Natschke SL; Lee EY; Bastow KF; Lee KH
    Bioorg Med Chem Lett; 2011 Jan; 21(1):52-7. PubMed ID: 21147529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and in vitro evaluation against human cancer cells of 5-methyl-5-styryl-2,5-dihydrofuran-2-ones, a new series of goniothalamin analogues.
    Bruder M; Vendramini-Costa DB; de Carvalho JE; Pilli RA
    Bioorg Med Chem; 2013 Sep; 21(17):5107-17. PubMed ID: 23876338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of Nitrogen-Containing Goniothalamin Analogues with Higher Cytotoxic Activity and Selectivity against Cancer Cells.
    Meirelles MA; Braga CB; Ornelas C; Pilli RA
    ChemMedChem; 2019 Aug; 14(15):1403-1417. PubMed ID: 31260170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha.
    Lin W; Huang J; Liao X; Yuan Z; Feng S; Xie Y; Ma W
    Pharmacol Res; 2016 Sep; 111():849-858. PubMed ID: 27491559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel C-4 heteroaryl 13-cis-retinamide Mnk/AR degrading agents inhibit cell proliferation and migration and induce apoptosis in human breast and prostate cancer cells and suppress growth of MDA-MB-231 human breast and CWR22Rv1 human prostate tumor xenografts in mice.
    Mbatia HW; Ramalingam S; Ramamurthy VP; Martin MS; Kwegyir-Afful AK; Njar VC
    J Med Chem; 2015 Feb; 58(4):1900-14. PubMed ID: 25634130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An allomaltol derivative triggers distinct death pathways in luminal a and triple-negative breast cancer subtypes.
    Ercan A; Oncul S; Karakaya G; Aytemir M
    Bioorg Chem; 2020 Dec; 105():104403. PubMed ID: 33166845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic activity of (S)-goniothalamin and analogues against human cancer cells.
    Fátima Ad; Kohn LK; Carvalho JE; Pilli RA
    Bioorg Med Chem; 2006 Feb; 14(3):622-31. PubMed ID: 16202605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel 2, 5-dihydrofuran derivatives and evaluation of their anticancer activity.
    Zhang Y; Zhong H; Wang T; Geng D; Zhang M; Li K
    Eur J Med Chem; 2012 Feb; 48():69-80. PubMed ID: 22182926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pyrone side tetracyclic psoralen derivatives: synthesis and photobiological evaluation.
    Dalla Via L; Uriarte E; Quezada E; Dolmella A; Ferlin MG; Gia O
    J Med Chem; 2003 Aug; 46(18):3800-10. PubMed ID: 12930143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues.
    Wang W; Rayburn ER; Velu SE; Nadkarni DH; Murugesan S; Zhang R
    Clin Cancer Res; 2009 May; 15(10):3511-8. PubMed ID: 19451594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitumour activity of new muricatacin and goniofufurone analogues.
    Popsavin V; Srećo B; Krstić I; Popsavin M; Kojić V; Bogdanović G
    Eur J Med Chem; 2006 Oct; 41(10):1217-22. PubMed ID: 16891043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.